Covalon Technologies

Covalon Technologies Quick Ratio

Quick Ratio (Acid Test) of Covalon Technologies (COV.V) as of Oct 21, 2026.

Quick Ratio

-

Last updated:

Quick Ratio (Acid Test) of Covalon Technologies is 2026 - . Quick Ratio (Acid Test) of Covalon Technologies was 2025 3.85 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Covalon Technologies Stock analysis

What does Covalon Technologies do? Covalon Technologies Ltd. develops and markets patent-protected medical products including advanced wound care solutions, infection prevention technologies, and medical device coatings. The company sells products under its own brand name and also creates medical products for other medical companies through development and license contracts. Its solutions target patients requiring gentle healing with reduced infections and pain, while also serving care providers with specialized medical devices, dressings, and perioperative care systems. The company's portfolio includes antimicrobial skin protection, postoperative incision care, and scar prophylaxis solutions designed for comprehensive patient care from pre-operative to postoperative stages. Covalon's revenue streams come from direct sales of its branded products and licensing agreements with other medical companies for product development. The primary customers are healthcare providers and hospitals seeking advanced wound care and infection prevention solutions. The company focuses on medical device coatings, wound care products, and perioperative care systems as key segments within the medical technology market. Its patented technologies enable both direct product sales and collaborative development partnerships with other medical companies. The company's business model relies on two main revenue channels: selling Covalon-branded medical products directly to healthcare providers and generating income through development and license contracts with other medical companies. Its solutions are designed for patients and made for care providers, emphasizing gentle healing with less infections and pain. The company's product portfolio includes antimicrobial protection for pre-operative skin, postoperative incision care, and scar prophylaxis as part of its perioperative care offerings. Covalon Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Covalon Technologies stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Covalon Technologies since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Covalon Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Covalon Technologies

All Key Metrics — Covalon Technologies